The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission
Open accessAbstract
BACKGROUND: The in vivo clinical significance of malignant stem cells remains unclear. METHODS: Patients who have the 5q deletion (del[5q]) myelodysplastic syndrome (interstitial deletions involving the long arm of chromosome 5) have complete clinical and cytogenetic remissions in response to lenalidomide treatment, but they often have relapse. To determine whether the persistence of rare but distinct malignant stem cells accounts for such relapses, we examined bone marrow specimens obtained from seven patients with the del(5q) myelodysplastic syndrome who became transfusion-independent while receiving lenalidomide treatment and entered cytogenetic remission. RESULTS: Virtually all CD34+, CD38+ progenitor cells and stem cells that were positive for CD34 and CD90, with undetectable or low CD38 (CD38−/low), had the 5q deletion before treatment. Although lenalidomide efficiently reduced these progenitors in patients in complete remission, a larger fraction of the minor, quiescent, CD34+,CD38-/low, CD90+ del(5q) stem cells as well as functionally defined del(5q) stem cells remained distinctly resistant to lenalidomide. Over time, lenalidomide resistance developed in most of the patients in partial and complete remission, with recurrence or expansion of the del(5q) clone and clinical and cytogenetic progression. CONCLUSIONS: In these patients with the del(5q) myelodysplastic syndrome, we identified rare and phenotypically distinct del(5q) myelodysplastic syndrome stem cells that were also selectively resistant to therapeutic targeting at the time of complete clinical and cytogenetic remission. (Funded by the EuroCancerStemCell Consortium and others.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Efficient tumour formation by single human melanoma cells
Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061292 · Cited by 1,319
Self-citationEfficacy of Lenalidomide in Myelodysplastic Syndromes
List, A., Kurtin, S., Roe, D. J., Buresh, A., Mahadevan, D., Fuchs, D., Rimsza, L., Heaton, R., Knight, R., & Zeldis, J. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041668 · Cited by 880
Self-citationPurification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
Bhatia, M., Wang, J. C. Y., Kapp, U., Bonnet, D., & Dick, J. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5320 · Cited by 850
Terstappen, L., Huang, S., Safford, M., Lansdorp, P., & Loken, M. (1991) · Blood · doi:10.1182/blood.v77.6.1218.1218 · Cited by 847
Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells
Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L., & Strasser, A. (2007) · Science · doi:10.1126/science.1142596 · Cited by 827
Jordan, C., Upchurch, D., Szilvassy, S., Guzman, M., Howard, D., Pettigrew, A., Meyerrose, T., Rossi, R., Grimes, B., Rizzieri, D., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401903 · Cited by 821
Sutherland, H., Eaves, C., Eaves, A., Dragowska, W., & Lansdorp, P. (1989) · Blood · doi:10.1182/blood.v74.5.1563.1563 · Cited by 681
Sutherland, H. J., Lansdorp, P. M., Henkelman, D. H., Eaves, A. C., & Eaves, C. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3584 · Cited by 648
Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A. M., & Sauvageau, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3714 · Cited by 640
Jin, L., Lee, E. M., Ramshaw, H. S., Busfield, S. J., Peoppl, A. G., Wilkinson, L., Guthridge, M. A., Thomas, D., Barry, E. F., Boyd, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.04.018 · Cited by 522
Cancer stem cells in solid tumors
Ailles, L. E., & Weissman, I. L. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.007 · Cited by 512
Distinct haematological disorder with deletion of long arm of No. 5 chromosome
VAN DEN BERGHE, H., CASSIMAN, J.-J., DAVID, G., FRYNS, J.-P., MICHAUX, J.-L., & SOKAL, G. (1974) · Nature · doi:10.1038/251437a0 · Cited by 442
Sato, T., Onai, N., Yoshihara, H., Arai, F., Suda, T., & Ohteki, T. (2009) · Nature Medicine · doi:10.1038/nm.1973 · Cited by 418
Taussig, D. C., Miraki-Moud, F., Anjos-Afonso, F., Pearce, D. J., Allen, K., Ridler, C., Lillington, D., Oakervee, H., Cavenagh, J., Agrawal, S. G., et al. (2008) · Blood · doi:10.1182/blood-2007-10-118331 · Cited by 373
Petzer, A. L., Hogge, D. E., Landsdorp, P. M., Reid, D. S., & Eaves, C. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1470 · Cited by 350
Nimer, S. D. (2008) · Blood · doi:10.1182/blood-2007-08-078139 · Cited by 336
Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity
Laurenti, E., Varnum-Finney, B., Wilson, A., Ferrero, I., Blanco-Bose, W. E., Ehninger, A., Knoepfler, P. S., Cheng, P.-F., MacDonald, H. R., Eisenman, R. N., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.005 · Cited by 305
le Viseur, C., Hotfilder, M., Bomken, S., Wilson, K., Röttgers, S., Schrauder, A., Rosemann, A., Irving, J., Stam, R. W., Shultz, L. D., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.015 · Cited by 289
Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 Leukemia
Wei, J., Wunderlich, M., Fox, C., Alvarez, S., Cigudosa, J. C., Wilhelm, J. S., Zheng, Y., Cancelas, J. A., Gu, Y., Jansen, M., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.020 · Cited by 284
Melchert, M., & List, A. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.022 · Cited by 246
Self-citationNilsson, L., Åstrand-Grundström, I., Arvidsson, I., Jacobsson, B., Hellström-Lindberg, E., Hast, R., & Jacobsen, S. E. W. (2000) · Blood · doi:10.1182/blood.v96.6.2012 · Cited by 241
Self-citationVerhelle, D., Corral, L. G., Wong, K., Mueller, J. H., Moutouh-de Parseval, L., Jensen-Pergakes, K., Schafer, P. H., Chen, R., Glezer, E., Ferguson, G. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2317 · Cited by 234
Intermediate-Term Hematopoietic Stem Cells with Extended but Time-Limited Reconstitution Potential
Benveniste, P., Frelin, C., Janmohamed, S., Barbara, M., Herrington, R., Hyam, D., & Iscove, N. N. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2009.11.014 · Cited by 216
Hogge, D., Lansdorp, P., Reid, D., Gerhard, B., & Eaves, C. (1996) · Blood · doi:10.1182/blood.v88.10.3765.bloodjournal88103765 · Cited by 207
Wei, S., Chen, X., Rocha, K., Epling-Burnette, P. K., Djeu, J. Y., Liu, Q., Byrd, J., Sokol, L., Lawrence, N., Pireddu, R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811267106 · Cited by 192
Self-citationTargeting the leukemic stem cell: the Holy Grail of leukemia therapy
Misaghian, N., Ligresti, G., Steelman, L. S., Bertrand, F. E., Bäsecke, J., Libra, M., Nicoletti, F., Stivala, F., Milella, M., Tafuri, A., et al. (2009) · Leukemia · doi:10.1038/leu.2008.246 · Cited by 187
Moutouh-de Parseval, L. A., Verhelle, D., Glezer, E., Jensen-Pergakes, K., Ferguson, G. D., Corral, L. G., Morris, C. L., Muller, G., Brady, H., & Chan, K. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32322 · Cited by 182
Nilsson, L., Åstrand-Grundström, I., Anderson, K., Arvidsson, I., Hokland, P., Bryder, D., Kjeldsen, L., Johansson, B., Hellström-Lindberg, E., Hast, R., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0188 · Cited by 163
Self-citationAdès, L., Boehrer, S., Prébet, T., Beyne‐Rauzy, O., Legros, L., Ravoet, C., Dreyfus, F., Stamatoullas, A., Chaury, M., Delaunay, J., et al. (2008) · Blood · doi:10.1182/blood-2008-08-175778 · Cited by 152
Glimm, H., & Eaves, C. J. (1999) · Blood · doi:10.1182/blood.v94.7.2161.419k32_2161_2168 · Cited by 142
Nilsson, L., Edén, P., Olsson, E., Månsson, R., Åstrand‐Grundström, I., Strömbeck, B., Theilgaard‐Mönch, K., Anderson, K., Hast, R., Hellström‐Lindberg, E., et al. (2007) · Blood · doi:10.1182/blood-2007-03-079368 · Cited by 115
Self-citationJädersten, M., Saft, L., Pellagatti, A., Göhring, G., Wainscoat, J. S., Boultwood, J., Porwit‐MacDonald, A., Schlegelberger, B., & Hellström‐Lindberg, E. (2009) · Haematologica · doi:10.3324/haematol.2009.011528 · Cited by 101
Self-citationGandhi, A. K., Kang, J., Naziruddin, S., Parton, A., Schafer, P. H., & Stirling, D. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.01.010 · Cited by 95
Hox Genes: From Leukemia to Hematopoietic Stem Cell Expansion
Abramovich, C., Pineault, N., OHTA, H., & Humphries, R. K. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1349.014 · Cited by 81
Göhring, G., Giagounidis, A. A. N., Büsche, G., Kreipe, H. H., Zimmermann, M., Hellström‐Lindberg, E., Aul, C., & Schlegelberger, B. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0846-z · Cited by 80
Self-citationHematopoietic stem cell self-renewal
Akala, O. O., & Clarke, M. F. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.08.011 · Cited by 75
Éclache, V., Rocha, A. D., Roux, G. L., & Fenaux, P. (2008) · Haematologica · doi:10.3324/haematol.11917 · Cited by 7
Cited by
Evolution of the Cancer Stem Cell Model
Kreso, A., & Dick, J. E. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,224
Cancer Stem Cells: Current Status and Evolving Complexities
Visvader, J. E., & Lindeman, G. J. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.007 · Cited by 1,287
Self-renewal as a therapeutic target in human colorectal cancer
Kreso, A., van Galen, P., Pedley, N. M., Lima-Fernandes, E., Frelin, C., Davis, T., Cao, L., Baiazitov, R., Du, W., Sydorenko, N., et al. (2014) · Nature Medicine · doi:10.1038/nm.3418 · Cited by 500
Cazzola, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1904794 · Cited by 491
Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells
Notta, F., Mullighan, C. G., Wang, J. C. Y., Poeppl, A., Doulatov, S., Phillips, L. A., Ma, J., Minden, M. D., Downing, J. R., & Dick, J. E. (2011) · Nature · doi:10.1038/nature09733 · Cited by 463
Metadata
- Authors
- Tehranchi, R., Woll, P. S., Anderson, K., Buza-Vidas, N., Mizukami, T., Mead, A. J., Åstrand-Grundström, I., Strömbeck, B., Horvat, A., Ferry, H., Dhanda, R. S., Hast, R., Rydén, T., Vyas, P., Göhring, G., Schlegelberger, B., Johansson, B., Hellström-Lindberg, E., List, A., Nilsson, L., & Jacobsen, S. E. W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-09-09
- Volume
- 363
- Issue
- 11
- Pages
- 1025-1037
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2095486213
- Cited by
- 253
- References
- 40
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.